WuXi Biologics Successfully Completes First Scale-Up of High-Productivity Bioprocessing Platform WuXiUI™ in 2,000L GMP Manufacturing
By leveraging its ultra-intensified fed-batch platform, WuXiUI, WuXi Biologics has [...]
By leveraging its ultra-intensified fed-batch platform, WuXiUI, WuXi Biologics has [...]
The new ICMRA program is designed to abbreviate the time [...]
“Our Nanovial Multicell Assays are a game-changer, opening up new [...]
“This project represents a paradigm shift towards improving viral vector [...]
HT-KIT cancer therapeutic is an antisense oligonucleotide that targets the [...]
NEC Bio Therapeutics, a Mannheim based German company focused on [...]
“Our partnership with SAS amplifies the core strengths of both [...]
Razi Ingber, RedHill Biopharma and Chief Financial Officer, said: “We [...]
This landmark project will focus on the opportunity for AI [...]
Mikhail Kalinichev, Head of Translational Science, will present at the [...]